BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20180101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190416
DTEND;VALUE=DATE:20190419
DTSTAMP:20260514T214547
CREATED:20190220T073216Z
LAST-MODIFIED:20190220T073349Z
UID:19646-1555372800-1555631999@www.pharmajournalist.com
SUMMARY:Neuroimmunology Drug Development Summit (NIDD)
DESCRIPTION:Built with thought-leaders at Sanofi\, Eisai\, AbbVie and Denali\, the inaugural NIDD Summit will share the field’s cutting-edge scientific advances enabling you to translate your neuroimmunology research into a clinically effective therapeutic for neurological diseases. \n\nWith an emphasis on neurodegeneration\, chronic neuroinflammatory mechanisms will be explored whilst addressing your drug development challenges: \n\nDiscover robust biomarkers of neuroinflammation to enable successful translation and patient stratification\nNavigate preclinical model limitations to better predict clinical efficacy\nExplore the identification and validation of neuroimmunological targets and assess novel therapeutic approaches\n\nDon’t miss this opportunity to learn from 20+ industry expert speakers to effectively target neuroimmunological mechanisms and rapidly progress your research to the clinic. \nFor more information\, visit www.neuroimmunology-drugdevelopment.com
URL:https://www.pharmajournalist.com/event/neuroimmunology-drug-development-summit-nidd/
LOCATION:Hyatt Regency Boston  One Avenue de Lafayette\, Boston  Massachusetts\, United States\, 02111
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR